|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$5,965,895 |
|
|
Indirect Value
|
$5,479,085 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-03-06 |
4 |
D |
$32.33 |
$1,286,217 |
D/D |
(39,784) |
298,840 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-09-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(250,788) |
298,840 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-09-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,950) |
16,809 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-03 |
4 |
D |
$37.15 |
$893,123 |
D/D |
(24,041) |
111,753 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-04 |
4 |
D |
$36.94 |
$142,773 |
D/D |
(3,865) |
115,341 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-07 |
4 |
D |
$37.53 |
$2,816,214 |
D/D |
(75,039) |
185,021 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2017-06-15 |
4 |
D |
$90.00 |
$1,165,500 |
I/I |
(12,950) |
0 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2017-06-15 |
4 |
D |
$90.00 |
$1,234,890 |
D/D |
(13,721) |
0 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2019-12-17 |
4 |
D |
$114.50 |
$1,627,503 |
D/D |
(14,214) |
0 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
200,630 |
100,315 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,360 |
5,180 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-12-04 |
4 |
GD |
$25.14 |
$125,700 |
D/D |
5,000 |
165,634 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
200,630 |
50,158 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,360 |
2,590 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2009-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
ONCE |
Spark Therapeutics, Inc. |
Director |
|
2015-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,214 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,043 |
223,044 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
196,526 |
0 |
- |
|
MJN |
Mead Johnson Nutrition Co |
Director |
|
2011-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,160 |
15,110 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
250,496 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
212,462 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
214,559 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
217,979 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
OE |
$28.90 |
$7,502,803 |
D/D |
259,600 |
470,838 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-18 |
4 |
OE |
$28.70 |
$5,326,321 |
D/D |
185,579 |
356,931 |
0 |
- |
|
133 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|